Cargando…

Commentary: Basophil Activation-Dependent Autoantibody and Interleukin-17 Production Exacerbate Systemic Lupus Erythematosus

Detalles Bibliográficos
Autores principales:	Poddighe, Dimitri, Marseglia, Gian Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500626/ https://www.ncbi.nlm.nih.gov/pubmed/28736553 http://dx.doi.org/10.3389/fimmu.2017.00787

Ejemplares similares

Basophil Activation-Dependent Autoantibody and Interleukin-17 Production Exacerbate Systemic Lupus Erythematosus
por: Pan, Qingjun, et al.
Publicado: (2017)

Basophils and Systemic Lupus Erythematosus in Murine Models and Human Patients
por: Dossybayeva, Kuanysh, et al.
Publicado: (2020)

Analysis of Peripheral Blood Basophils in Pediatric Systemic Lupus Erythematosus
por: Dossybayeva, Kuanysh, et al.
Publicado: (2022)

Mechanisms of Autoantibody Production in Systemic Lupus Erythematosus
por: Han, Shuhong, et al.
Publicado: (2015)

Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus
por: Cocco, Cristina, et al.
Publicado: (2023)

Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA
por: Becker, Yann, et al.
Publicado: (2019)

Autoantibodies Against Albumin in Patients With Systemic Lupus Erythematosus
por: Nehring, Josephine, et al.
Publicado: (2018)

Commentary: T cell metabolism: a new perspective on Th17/Treg cell imbalance in systemic lupus erythematosus
por: Jin, Jiamei, et al.
Publicado: (2023)

Epitope-Specific Anti-C1q Autoantibodies in Systemic Lupus Erythematosus
por: Kleer, Jessica S., et al.
Publicado: (2022)

Commentary: The Expression of CD123 Can Decrease with Basophil Activation: Implications for the Gating Strategy of the Basophil Activation Test
por: Chirumbolo, Salvatore
Publicado: (2016)

Commentary: Mutual interaction of basophils and T cells in chronic inflammatory diseases
por: Chirumbolo, Salvatore
Publicado: (2016)

Is There any Relationship Between Extra-Pulmonary Manifestations of Mycoplasma Pneumoniae Infection and Atopy/Respiratory Allergy in Children?
por: Poddighe, Dimitri, et al.
Publicado: (2016)

Commentary: Systemic lupus erythematosus and cardiovascular disease: A Mendelian randomization study
por: Kerns, Sophia, et al.
Publicado: (2022)

Autoantibodies to Cytosolic 5′-Nucleotidase 1A in Primary Sjögren’s Syndrome and Systemic Lupus Erythematosus
por: Rietveld, Anke, et al.
Publicado: (2018)

Clinical Relevance of Autoantibodies against Interleukin-2 in Patients with Systemic Lupus Erythematosus
por: Shao, Miao, et al.
Publicado: (2018)

IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production
por: Pan, Qingjun, et al.
Publicado: (2020)

Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus
Publicado: (1995)

Autoantibodies Recognizing Secondary NEcrotic Cells Promote Neutrophilic Phagocytosis and Identify Patients With Systemic Lupus Erythematosus
por: Biermann, Mona H. C., et al.
Publicado: (2018)

Role of autoantibodies and blood–brain barrier leakage in cognitive impairment in systemic lupus erythematosus
por: Hanly, John G, et al.
Publicado: (2022)

Clinical associations of serum interleukin-17 in systemic lupus erythematosus
por: Vincent, Fabien B, et al.
Publicado: (2013)

Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus
por: Mende, Rachel, et al.
Publicado: (2018)

Editorial: Systemic Lupus Erythematosus and Antiphospholipid Syndrome
por: Meroni, Pier Luigi, et al.
Publicado: (2019)

Autoantibodies to Killer Cell Immunoglobulin-Like Receptors in Patients With Systemic Lupus Erythematosus Induce Natural Killer Cell Hyporesponsiveness
por: Segerberg, Filip, et al.
Publicado: (2019)

Serum Interleukin-26 Is a New Biomarker for Disease Activity Assessment in Systemic Lupus Erythematosus
por: Brilland, Benoit, et al.
Publicado: (2021)

Pathogenesis and novel therapeutics of regulatory T cell subsets and interleukin-2 therapy in systemic lupus erythematosus
por: Tsai, Yi-Giien, et al.
Publicado: (2023)

Autoantibodies and cognitive impairment in systemic lupus erythematosus
por: Kowal, C, et al.
Publicado: (2004)

Anti-Cytokine Autoantibodies in Systemic Lupus Erythematosus
por: Howe, Hwee Siew, et al.
Publicado: (2019)

Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling
por: Mike, Elise V., et al.
Publicado: (2018)

Current Insights and Future Prospects for Targeting IL-17 to Treat Patients With Systemic Lupus Erythematosus
por: Koga, Tomohiro, et al.
Publicado: (2021)

The effect of combining PD-1 agonist and low-dose Interleukin-2 on treating systemic lupus erythematosus
por: Wang, Bing, et al.
Publicado: (2023)

Acalculous Acute Cholecystitis in Previously Healthy Children: General Overview and Analysis of Pediatric Infectious Cases
por: Poddighe, Dimitri, et al.
Publicado: (2015)

Disturbed T Cell Signaling and Altered Th17 and Regulatory T Cell Subsets in the Pathogenesis of Systemic Lupus Erythematosus
por: Rother, Nils, et al.
Publicado: (2015)

Altered Th17/Treg Ratio in Peripheral Blood of Systemic Lupus Erythematosus but Not Primary Antiphospholipid Syndrome
por: Álvarez-Rodríguez, Lorena, et al.
Publicado: (2019)

T Cell Metabolism: A New Perspective on Th17/Treg Cell Imbalance in Systemic Lupus Erythematosus
por: Shan, Juan, et al.
Publicado: (2020)

A High Prevalence of Anti-EBNA1 Heteroantibodies in Systemic Lupus Erythematosus (SLE) Supports Anti-EBNA1 as an Origin for SLE Autoantibodies
por: Laurynenka, Viktoryia, et al.
Publicado: (2022)

Editorial: Focus on Systemic Lupus Erythematosus
por: Harris, James, et al.
Publicado: (2016)

HMGB1 in Systemic Lupus Erythematosus
por: Liu, Tianye, et al.
Publicado: (2020)

Two Major Autoantibody Clusters in Systemic Lupus Erythematosus
por: Ching, Kathryn H., et al.
Publicado: (2012)

Cytokine and autoantibody clusters interaction in systemic lupus erythematosus
por: Pacheco, Yovana, et al.
Publicado: (2017)

CD16(+) Monocyte Subset Was Enriched and Functionally Exacerbated in Driving T-Cell Activation and B-Cell Response in Systemic Lupus Erythematosus
por: Zhu, Huaqun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_roc5uqm5drl8qn71ujt4tgp6np